Does COPANLISIB Cause Diffuse large b-cell lymphoma? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Diffuse large b-cell lymphoma have been filed in association with COPANLISIB. This represents 2.3% of all adverse event reports for COPANLISIB.
8
Reports of Diffuse large b-cell lymphoma with COPANLISIB
2.3%
of all COPANLISIB reports
0
Deaths
8
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma From COPANLISIB?
Of the 8 reports, 8 (100.0%) required hospitalization.
Is Diffuse large b-cell lymphoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for COPANLISIB. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does COPANLISIB Cause?
Pyrexia (58)
Off label use (43)
Hyperglycaemia (27)
Hypertension (24)
Rash maculo-papular (24)
Pneumonia (20)
Sepsis (19)
Diarrhoea (18)
Rash (16)
Febrile neutropenia (15)
What Other Drugs Cause Diffuse large b-cell lymphoma?
RITUXIMAB (1,571)
CYCLOPHOSPHAMIDE (1,183)
PREDNISONE (1,062)
METHOTREXATE (1,055)
VINCRISTINE (1,043)
DOXORUBICIN (1,002)
LENALIDOMIDE (779)
TACROLIMUS (595)
DEXAMETHASONE (539)
PREDNISOLONE (506)
Which COPANLISIB Alternatives Have Lower Diffuse large b-cell lymphoma Risk?
COPANLISIB vs COPAXONE
COPANLISIB vs COPEGUS
COPANLISIB vs COPPER
COPANLISIB vs CORDARONE
COPANLISIB vs CORICIDIN HBP COLD AND FLU